A New York Times health reporter explains what clinical trials are, why they are important and how they can help inform us.

The shift to risk-based quality management (RBQM) in clinical trials offers market opportunities in proactive risk strategies, focusing on patient safety and data integrity. Emphasizing digital ...

MILWAUKEE, WI, November 19, 2024 (EZ Newswire) -- As biopharmaceutical sponsors face increasing challenges in securing investigative sites for their clinical trials, the ability to reduce ...

As biotechs scale up, streamlining the planning, execution, and monitoring of outsourced clinical trials becomes critical. While CROs manage the day-to-day operations, sponsors are ultimately ...

To better recognise its potential to address the challenge of white space in clinical trials, it helps to first understand ...

Despite rapid growth, only 9.2% of DCTs are multiregional and over 80% single-country, indicating challenges in international implementation. 2 With regulatory agencies 4–7 underscoring risk-based ...

Expertise from Forbes Councils members, operated under license. Opinions expressed are those of the author. With more than a third of hospitals experiencing negative operating margins, healthcare ...

In today's fast-paced and ever-evolving landscape of clinical trials, the ability to efficiently analyze and visualize data has become paramount. The vast amounts of data generated from these trials ...